2013年3月1日

MTX治療子宮外孕並不會影響日後卵巢之功能及懷孕率

MTX治療子宮外孕並不會影響日後卵巢之功能及懷孕率



 2013 Jul 10. pii: S0015-0282(13)00707-3. doi: 10.1016/j.fertnstert.2013.06.013. [Epub ahead of print]

Medical treatment of ectopic pregnancy: a committee opinion.

Source

American Society for Reproductive Medicine, Birmingham, Alabama.

Abstract

Methotrexate, a folic acid antagonist, is an effective treatment for early unruptured ectopic pregnancy. Several treatment regimens are available. Methotrexate is more effective when used to treat ectopic pregnancies with lower human chorionic gonadotropin (hCG) levels. However, there is no consensus on a threshold value that best predicts success or failure. Methotrexate can be used to treat ectopic pregnancies that occur in cornual, cervical, and cesarean scar locations, and it does not adversely affect ovarian reserve or subsequent fertility. This document replaces the previous document of the same name, last published in 2008 (Fertil Steril 2008;90:S206-12).

沒有留言:

張貼留言